Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers

9 participants · First posted Oct 22, 2020

Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)

58 participants · First posted May 9, 2023

Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC

5 participants · First posted Dec 29, 2010

CEP-32215

Dual D2/H3 Receptor Antagonists (Angita)

Histamine(Activon Arthritis, Ceplene, Rematex)

C₅H₉N₃

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

3-D Matrix Ltd.

Japan

FDA Expands Pitolisant Label to Include Cataplexy Treatment in Pediatric Narcolepsy Patients

FDA Issues Refusal to File for Pitolisant in Idiopathic Hypersomnia Treatment

FDA Issues Refuse-to-File Letter for Wakix in Idiopathic Hypersomnia Treatment